No Data
No Data
ADRs End Lower; Adlai Nortye Ltd. Declines 20%
Adlai Nortye Ltd.'s (NASDAQ:ANL) Market Cap Surged US$56m Last Week, Individual Investors Who Have a Lot Riding on the Company Were Rewarded
Positive Buy Recommendation for Adlai Nortye Ltd.'s AN4005: Promising Clinical Trial Results and Unique Drug Features
H.C. Wainwright Maintains Adlai Nortye(ANL.US) With Buy Rating, Maintains Target Price $9
Adlai Nortye Ltd. Sponsored ADR (ANL) Loses -33.06% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Adlai Nortye Ltd. (NASDAQ:ANL) Stock Most Popular Amongst Retail Investors Who Own 42%, While Employee Share Scheme Hold 29%
No Data
No Data